SHLTN — SHL Telemedicine Income Statement
0.000.00%
Last trade - 00:00
- CH₣88.51m
- CH₣87.06m
- $59.00m
- 19
- 36
- 23
- 14
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 48.9 | 41.9 | 40.2 | 49.6 | 59 |
Cost of Revenue | |||||
Gross Profit | 30.2 | 23.5 | 20.6 | 24.6 | 27.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.9 | 36.8 | 39.8 | 50.1 | 64.2 |
Operating Profit | 12 | 5.08 | 0.396 | -0.497 | -5.17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.5 | 4.77 | 0.077 | -13.5 | 1.31 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.1 | 5.7 | 0.278 | -13.9 | 0.215 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 10.1 | 5.7 | 0.278 | -14.1 | -0.076 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.1 | 5.7 | 0.278 | -14.1 | -0.076 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.944 | 0.565 | 0.029 | -0.972 | -0.005 |
Dividends per Share |